![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
COVID-19: Potential Vaccines and Logistics
While pharmaceuticals contribute to approximately 2% of annual air cargo volume, the industry transports over one trillion dollars’ worth of cargo every year (IATA)....
News
China grants country’s first Covid-19 vaccine patent to CanSino
China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents...
News
Covaxin: Bharat Biotech-ICMR developed vaccine is safe, show preliminary results
The preliminary results of phase 1 clinical trials of Bharat Biotech-ICMR developed Covaxin, a COVID-19 vaccine, has shown that the vaccine is safe. The...
News
Russia’s COVID-19 vaccine to enter production, deliver first batch of doses in two weeks
The world's first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry...
News
TIACA and Pharma.Aero Join Forces to Prepare Air Cargo Industry for COVID-19 Vaccine
The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation...
News
FDA Accepts Biogens Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review
Biogen and Eisai, Co., Ltd. announced that the U.S. FDA has accepted the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s...
Press Releases
Regeneron Announces FDA Accepts Evinacumab BLA for Priority Review as Treatment for Patients with HoFH
Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has accepted for Priority Review a Biologics License Application (BLA) for evinacumab as an adjunct to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
